Daniel P. Gold Phd - Jul 1, 2021 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role
Chief Executive Officer, Director
Signature
/s/ Brian G. Drazba, as attorney in fact
Stock symbol
MEIP
Transactions as of
Jul 1, 2021
Transactions value $
-$121,481
Form type
4
Date filed
7/6/2021, 06:47 PM
Previous filing
May 27, 2021
Next filing
Jul 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MEIP Common Stock Tax liability -$121K -41.3K -9.01% $2.94 417K Jul 2, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEIP Stock Option (Right to Buy) Award $0 +855K $0.00 855K Jul 1, 2021 Common Stock 855K $2.95 Direct F2
holding MEIP Stock Option (Right to Buy) 276K Jul 1, 2021 Common Stock 276K $1.57 Direct F3
holding MEIP Stock Option (Right to Buy) 380K Jul 1, 2021 Common Stock 380K $1.36 Direct F3
holding MEIP Stock Option (Right to Buy) 380K Jul 1, 2021 Common Stock 380K $2.83 Direct F4
holding MEIP Stock Option (Right to Buy) 380K Jul 1, 2021 Common Stock 380K $4.33 Direct F5
holding MEIP Stock Option (Right to Buy) 300K Jul 1, 2021 Common Stock 300K $4.28 Direct F6
holding MEIP Stock Option (Right to Buy) 675K Jul 1, 2021 Common Stock 675K $2.52 Direct F7
holding MEIP Stock Option (Right to Buy) 680K Jul 1, 2021 Common Stock 680K $3.49 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by and surrendered to the Issuer on July 2, 2021, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units.
F2 One-quarter of such options shall vest on July 1, 2022 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.
F3 All of such options are presently exercisable.
F4 One-quarter of such options vested on July 6, 2018 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 6, 2018.
F5 One-quarter of such options vested on June 22, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019.
F6 One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
F7 One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
F8 One-quarter of such options vested on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.